Connect with us

The Conversation

Just 3 Nobel Prizes cover all of science – how research is done today poses a challenge for these prestigious awards

Published

on

Just 3 Nobel Prizes cover all of science – how research is done today poses a challenge for these prestigious awards

Has the Nobel Prize category ‘chemistry’ morphed into ‘biochemistry’?
picture alliance via Getty Images

Jeffrey I. Seeman, University of Richmond

I’ve been primarily an experimental chemist – the kind of person who goes into the laboratory and mixes and stirs chemicals – since the beginning of my career in 1965. Today, and for the past 15 years, I’m a full-time historian of chemistry.

Every October, when the announcements are made of that year’s Nobel laureates, I examine the results as a chemist. And all too often, I share the same response as many of my fellow chemists: “Who are they? And what did they do?”

One reason for that bewilderment – and disappointment – is that in many recent years, none of my “favorites” or those of my fellow chemists will travel to Stockholm. I am not suggesting that these Nobel laureates are undeserving – quite the opposite. Rather, I am questioning whether some of these awards belong within the discipline of chemistry.

Consider some recent Nobel Prizes. In 2020, Emmanuelle Charpentier and Jennifer A. Doudna received the Nobel Prize “for the development of a method for genome editing.” In 2018, Frances H. Arnold received the Nobel Prize “for the directed evolution of enzymes,” which she shared with George P. Smith and Sir Gregory P. Winter “for the phage display of peptides and antibodies.” In 2015, Tomas Lindahl, Paul Modrich and Aziz Sancar received the Nobel Prize “for mechanistic studies of DNA repair.”

All of them received Nobel Prizes in chemistry – not the Nobel Prize in physiology or medicine, even though these achievements seem very clearly situated within the disciplines of medicine and the life sciences. There are many other similar examples.

woman and man in formal dress at awards ceremony
2018 co-laureate Frances Arnold receives her Nobel Prize in chemistry from King Carl XVI Gustaf of Sweden.
Henrik Montgomery/AFP via Getty Images

These recent mismatches are even clearer when you look further back in time. Consider the 1962 Nobel Prize awarded to Francis Crick, James Watson and Maurice Wilkins “for their discoveries concerning the molecular structure of nucleic acids and its significance for information transfer in living material.” DNA, of course, is the most famous nucleic acid, and these three scientists were honored for deciphering how its atoms are bonded together and arranged in their three-dimensional double-helix shape.

While the “structure of DNA” most certainly is an achievement in chemistry, the Nobel Assembly at the Karolinska Institute in Stockholm awarded the Nobel Prize in physiology or medicine to Watson, Crick and Wilkins. Clearly, their Nobel achievements have had great consequences in the life sciences, genetics and medicine. Thus awarding them the Nobel Prize for physiology or medicine is quite appropriate.

metal model of structure of DNA molecule double helix
A model of a DNA molecule using some of Watson and Crick’s original metal plates.
Science & Society Picture Library via Getty Images

But note the disconnect. The Nobel Prizes in chemistry in 2020, 2018 and 2015 are more life-science- and medicine-oriented than Watson, Crick and Wilkins’ for the structure of DNA. Yet the former were awarded in chemistry, while the latter was in physiology and medicine.

What is going on? What does this trend reveal about the Nobel Foundation and its award strategies in response to the growth of science?

A gradual evolution in the Nobel Prizes

Several years ago, chemist-historian-applied mathematician Guillermo Restrepo and I collaborated to study the relationship of scientific discipline to the Nobel Prize.

Each year, the Nobel Committee for chemistry studies the nominations and proposes the recipients of the Nobel Prize in chemistry to its parent organization, the Royal Swedish Academy of Sciences, which ultimately selects the Nobel laureates in chemistry (and physics).

We found a strong correlation between the disciplines of the members of the committee and the disciplines of the awardees themselves. Over the lifetime of the Nobel Prizes, there has been a continuous increase – from about 10% in the 1910s to 50% into the 2000s – in the percentage of committee members whose research is best identified within the life sciences.

Restrepo and I concluded: As go the expertise, interests and the disciplines of the committee members, so go the disciplines honored by the Nobel Prizes in chemistry. We also concluded that the academy has intentionally included more and more life scientists on their selection committee for chemistry.

Now some perceptive readers might ask, “Is not the discipline of biochemistry just a subdiscipline of chemistry?” The underlying question is, “How does one define the disciplines in science?”

Restrepo and I reasoned that what we term “intellectual territory” defines the boundaries of a discipline. Intellectual territory can be assessed by bibliographic analysis of the scientific literature. We examined the references, often called citations, that are found in scientific publications. These references are where authors of journal articles cite the related research that’s previously been published – often the research they have relied and built on. We chose to study two journals: a chemistry journal named Angewandte Chemie and a life science journal named, rather aptly, Biochemistry.

We found that the articles in Angewandte Chemie mostly cite articles published in other chemistry journals, and the articles in Biochemistry mostly cite articles in biochemistry and life sciences journals. We also found that the reverse is true: Scientific publications that cite Angewandte Chemie articles are mostly in chemistry journals, and publications that cite Biochemistry articles are mostly in biochemistry and life science journals. In other words, chemistry and the life sciences/biochemistry reside in vastly different intellectual territories that don’t tend to overlap much.

Not letting labels be limiting

But now, perhaps a shocker. Many scientists don’t really care how they are classified by others. Scientists care about science.

As I’ve heard Dudley Herschbach, recipient of the 1986 Nobel Prize in chemistry, respond to the oft-asked question of whether he’s an experimental chemist or a theoretical chemist: “The molecules don’t know, nor do they care, do they?”

But scientists, like all human beings, do care about recognition and awards. And so, chemists do mind that the Nobel Prize in chemistry has morphed into the Nobel Prize in chemistry and the life sciences.

black and white head shot of man in early 20th C attire
Jacobus Henricus van ‘t Hoff received the first Nobel Prize in chemistry for ‘discovery of the laws of chemical dynamics and osmotic pressure in solutions.’
Universal History Archive/Universal Images Group via Getty Images

Since the Nobel Prizes were first awarded in 1901, the community of scientists and the number of scientific disciplines have grown tremendously. Even today, new disciplines are being created. New journals are appearing. Science is becoming more multidisciplinary and interdisciplinary. Even chemistry as a discipline has grown dramatically, pushing outward its own scholarly boundaries, and chemistry’s achievements continue to be astounding.

The Nobel Prize hasn’t evolved sufficiently with the times. And there just are not enough Nobel Prizes to go around to all the deserving.

I can imagine an additional Nobel Prize for the life sciences. The number of awardees could expand from the current three-per-prize maximum to whatever fits the accomplishment. Nobel Prizes could be awarded posthumously to make up for past serious omissions, an option that was used by the Nobel Foundation for several years and then discontinued.

In truth, the Nobel Foundation has evolved the prizes, but very deliberately and without the major transformations that I think will certainly be required in the future. It will, I believe, eventually break free, figuratively and literally, from the mire of Alfred Nobel’s will and more than a century of distinguished tradition.

When Nobel designed the prizes named after him in the late 1800s and early 1900s, he couldn’t have known that his gift would become a perpetual endowment and have such lasting – indeed, even increasing – significance. Nobel also could not have anticipated the growth of science, nor the fact that over time, some disciplines would fade in importance and new disciplines would evolve.

So far, the extremely competent and highly dedicated scholars at the Nobel Foundation and their partner organizations – and I acknowledge with real appreciation their selfless devotion to the cause – haven’t responded adequately to the growth of the sciences or to the inequities and even incompleteness of past award years. But I have confidence: In time, they will do so.The Conversation

Jeffrey I. Seeman, Visiting Research Scholar in Chemistry, University of Richmond

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Did you miss our previous article…
https://www.biloxinewsevents.com/?p=292254

The Conversation

Rural hospitals will be hit hard by Trump’s signature spending package

Published

on

theconversation.com – Lauren S. Hughes, State Policy Director, Farley Health Policy Center; Associate Professor of Family Medicine, University of Colorado Anschutz Medical Campus – 2025-07-06 13:38:00


The 2025 federal spending package signed by President Trump cuts Medicaid funding by over $1 trillion across a decade, risking 11.8 million Americans losing health coverage. Rural Americans—nearly 20% of the population—are especially vulnerable, as they rely heavily on Medicaid and face increased work requirements and red tape that will reduce coverage. These cuts will force rural hospitals to reduce services, lay off staff, delay equipment purchases, or close entirely. Despite a $50 billion Rural Health Transformation fund, the amount is insufficient to offset $155 billion in lost federal spending. Hospital closures threaten not only health access but also rural economies and the national economy.

Health policy experts predict that cuts to Medicaid will push more rural hospitals to close.
sneakpeekpic via iStock / Getty Images Plus

Lauren S. Hughes, University of Colorado Anschutz Medical Campus and Kevin J. Bennett, University of South Carolina

The public health provisions in the massive spending package that President Donald Trump signed into law on July 4, 2025, will reduce Medicaid spending by more than US$1 trillion over a decade and result in an estimated 11.8 million people losing health insurance coverage.

As researchers studying rural health and health policy, we anticipate that these reductions in Medicaid spending, along with changes to the Affordable Care Act, will disproportionately affect the 66 million people living in rural America – nearly 1 in 5 Americans.

People who live in rural areas are more likely to have health insurance through Medicaid and are at greater risk of losing that coverage. We expect that the changes brought about by this new law will lead to a rise in unpaid care that hospitals will have to provide. As a result, small, local hospitals will have to make tough decisions that include changing or eliminating services, laying off staff and delaying the purchase of new equipment. Many rural hospitals will have to reduce their services or possibly close their doors altogether.

Hits to rural health

The budget legislation’s biggest effect on rural America comes from changes to the Medicaid program, which represent the largest federal rollback of health insurance coverage in the U.S. to date.

First, the legislation changes how states can finance their share of the Medicaid program by restricting where funds states use to support their Medicaid programs can come from. This bill limits how states can tax and charge fees to hospitals, managed care organizations and other health care providers, and how they can use such taxes and fees in the future to pay higher rates to providers under Medicaid. These limitations will reduce payments to rural hospitals that depend upon Medicaid to keep their doors open.

Rural hospitals play a crucial role in health care access.

Second, by 2027, states must institute work requirements that demand most Medicaid enrollees work 80 hours per month or be in school at least half time. Arkansas’ brief experiment with work requirements in 2018 demonstrates that rather than boost employment, the policy increases bureaucracy, hindering access to health care benefits for eligible people. States will also now be required to verify Medicaid eligibility every six months versus annually. That change also increases the risk people will lose coverage due to extra red tape.

The Congressional Budget Office estimates that work requirements instituted through this legislative package will result in nearly 5 million people losing Medicaid coverage. This will decrease the number of paying patients at rural hospitals and increase the unpaid care hospitals must provide, further damaging their ability to stay open.

Additionally, the bill changes how people qualify for the premium tax credits within the Affordable Care Act Marketplace. The Congressional Budget Office estimates that this change, along with other changes to the ACA such as fewer and shorter enrollment periods and additional requirements for documenting income, will reduce the number of people insured through the ACA Marketplace by about 3 million by 2034. Premium tax credits were expanded during the COVID-19 pandemic, helping millions of Americans obtain coverage who previously struggled to do so. This bill lets these expanded tax credits expire, which with may result in an additional 4.2 million people becoming uninsured.

An insufficient stop-gap

Senators from both sides of the aisle have voiced concerns about the legislative package’s potential effects on the financial stability of rural hospitals and frontier hospitals, which are facilities located in remote areas with fewer than six people per square mile. As a result, the Senate voted to set aside $50 billion over the next five years for a newly created Rural Health Transformation Program.

These funds are to be allocated in two ways. Half will be directly distributed equally to states that submit an application that includes a rural health transformation plan detailing how rural hospitals will improve the delivery and quality of health care. The remainder will be distributed to states in varying amounts through a process that is currently unknown.

While additional funding to support rural health facilities is welcome, how it is distributed and how much is available will be critical. Estimates suggest that rural areas will see a reduction of $155 billion in federal spending over 10 years, with much of that concentrated in 12 states that expanded Medicaid under the Affordable Care Act and have large proportions of rural residents.

That means $50 billion is not enough to offset cuts to Medicaid and other programs that will reduce funds flowing to rural health facilities.

An older bearded white man in a yellow shirt sits on a hospital bed in an exam room
Americans living in rural areas are more likely to be insured through Medicaid than their urban counterparts.
Halfpoint Images/Moment via Getty Images

Accelerating hospital closures

Rural and frontier hospitals have long faced hardship because of their aging infrastructure, older and sicker patient populations, geographic isolation and greater financial and regulatory burdens. Since 2010, 153 rural hospitals have closed their doors permanently or ceased providing inpatient services. This trend is particularly acute in states that have chosen not to expand Medicaid via the Affordable Care Act, many of which have larger percentages of their residents living in rural areas.

According to an analysis by University of North Carolina researchers, as of June 2025 338 hospitals are at risk of reducing vital services, such as skilled nursing facilities; converting to an alternative type of health care facility, such as a rural emergency hospital; or closing altogether.

Maternity care is especially at risk.

Currently more than half of rural hospitals no longer deliver babies. Rural facilities serve fewer patients than those in more densely populated areas. They also have high fixed costs, and because they serve a high percentage of Medicaid patients, they rely on payments from Medicaid, which tends to pay lower rates than commercial insurance. Because of these pressures, these units will continue to close, forcing women to travel farther to give birth, to deliver before going full term and to deliver outside of traditional hospital settings.

And because hospitals in rural areas serve relatively small populations, they lack negotiating power to obtain fair and adequate payment from private health insurers and affordable equipment and supplies from medical companies. Recruiting and retaining needed physicians and other health care workers is expensive, and acquiring capital to renovate, expand or build new facilities is increasingly out of reach.

Finally, given that rural residents are more likely to have Medicaid than their urban counterparts, the legislation’s cuts to Medicaid will disproportionately reduce the rate at which rural providers and health facilities are paid by Medicaid for services they offer. With many rural hospitals already teetering on closure, this will place already financially fragile hospitals on an accelerated path toward demise.

Far-reaching effects

Rural hospitals are not just sources of local health care. They are also vital economic engines.

Hospital closures result in the loss of local access to health care, causing residents to choose between traveling longer distances to see a doctor or forgoing the services they need.

But hospitals in these regions are also major employers that often pay some of the highest wages in their communities. Their closure can drive a decline in the local tax base, limiting funding available for services such as roads and public schools and making it more difficult to attract and retain businesses that small towns depend on. Declines in rural health care undermine local economies.

Furthermore, the country as a whole relies on rural America for the production of food, fuel and other natural resources. In our view, further weakening rural hospitals may affect not just local economies but the health of the whole U.S. economy.The Conversation

Lauren S. Hughes, State Policy Director, Farley Health Policy Center; Associate Professor of Family Medicine, University of Colorado Anschutz Medical Campus and Kevin J. Bennett, Professor of Family and Preventive Medicine, University of South Carolina

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Read More

The post Rural hospitals will be hit hard by Trump’s signature spending package appeared first on theconversation.com



Note: The following A.I. based commentary is not part of the original article, reproduced above, but is offered in the hopes that it will promote greater media literacy and critical thinking, by making any potential bias more visible to the reader –Staff Editor.

Political Bias Rating: Center-Left

This content critically assesses a Republican-backed spending package signed by former President Donald Trump, highlighting its negative impacts on Medicaid and rural healthcare. The detailed discussion of the potential harm to vulnerable populations, emphasis on Medicaid cuts, and skepticism about work requirements align with a Center-Left perspective concerned with social welfare and public health. While it acknowledges bipartisan concern about rural hospital funding, the overall tone and focus on the consequences of policy changes reflect a moderate progressive lean rather than a purely neutral or conservative viewpoint.

Continue Reading

The Conversation

I’m a physician who has looked at hundreds of studies of vaccine safety, and here’s some of what RFK Jr. gets wrong

Published

on

theconversation.com – Jake Scott, Clinical Associate Professor of Infectious Diseases, Stanford University – 2025-06-26 07:31:00


Robert F. Kennedy Jr., since becoming Health and Human Services secretary, has made many false claims about vaccines, including exaggerating mandatory shots for children and alleging conflicts of interest among vaccine advisers. In reality, children receive about 30-32 required vaccine doses protecting against 10-12 diseases, far fewer than his claimed 92. Modern vaccines contain far fewer antigens and improved adjuvants, reducing immune burden. Controlled trials, including placebo comparisons, have tested all routine vaccines extensively. U.S. monitoring systems track vaccine safety continuously. Allegations of widespread conflicts of interest among advisers are unfounded, and vaccines have significantly reduced childhood illnesses and deaths.

Public health experts worry that factually inaccurate statements by Robert F. Kennedy Jr. threaten the public’s confidence in vaccines.
Andrew HarnikGetty Images

Jake Scott, Stanford University

In the four months since he began serving as secretary of the Department of Health and Human Services, Robert F. Kennedy Jr. has made many public statements about vaccines that have cast doubt on their safety and on the objectivity of long-standing processes established to evaluate them.

Many of these statements are factually incorrect. For example, in a newscast aired on June 12, 2025, Kennedy told Fox News viewers that 97% of federal vaccine advisers are on the take. In the same interview, he also claimed that children receive 92 mandatory shots. He has also widely claimed that only COVID-19 vaccines, not other vaccines in use by both children and adults, were ever tested against placebos and that “nobody has any idea” how safe routine immunizations are.

As an infectious disease physician who curates an open database of hundreds of controlled vaccine trials involving over 6 million participants, I am intimately familiar with the decades of research on vaccine safety. I believe it is important to correct the record – especially because these statements come from the official who now oversees the agencies charged with protecting Americans’ health.

Do children really receive 92 mandatory shots?

In 1986, the childhood vaccine schedule contained about 11 doses protecting against seven diseases. Today, it includes roughly 50 injections covering 16 diseases. State school entry laws typically require 30 to 32 shots across 10 to 12 diseases. No state mandates COVID-19 vaccination. Where Kennedy’s “92 mandatory shots” figure comes from is unclear, but the actual number is significantly lower.

From a safety standpoint, the more important question is whether today’s schedule with additional vaccines might be too taxing for children’s immune systems. It isn’t, because as vaccine technology improved over the past several decades, the number of antigens in each vaccine dose is much lower than before.

Antigens are the molecules in vaccines that trigger a response from the immune system, training it to identify the specific pathogen. Some vaccines contain a minute amount of aluminum salt that serves as an adjuvant – a helper ingredient that improves the quality and staying power of the immune response, so each dose can protect with less antigen.

Those 11 doses in 1986 delivered more than 3,000 antigens and 1.5 milligrams of aluminum over 18 years. Today’s complete schedule delivers roughly 165 antigens – which is a 95% reduction – and 5-6 milligrams of aluminum in the same time frame. A single smallpox inoculation in 1900 exposed a child to more antigens than today’s complete series.

A black-and-white photo of a doctor in a white coat giving an injection to a boy who is held by a female nurse.
Jonas Salk, the inventor of the polio vaccine, administers a dose to a boy in 1954.
Underwood Archives via Getty Images

Since 1986, the United States has introduced vaccines against Haemophilus influenzae type b, hepatitis A and B, chickenpox, pneumococcal disease, rotavirus and human papillomavirus. Each addition represents a life-saving advance.

The incidence of Haemophilus influenzae type b, a bacterial infection that can cause pneumonia, meningitis and other severe diseases, has dropped by 99% in infants. Pediatric hepatitis infections are down more than 90%, and chickenpox hospitalizations are down about 90%. The Centers for Disease Control and Prevention estimates that vaccinating children born from 1994 to 2023 will avert 508 million illnesses and 1,129,000 premature deaths.

Placebo testing for vaccines

Kennedy has asserted that only COVID-19 vaccines have undergone rigorous safety trials in which they were tested against placebos. This is categorically wrong.

Of the 378 controlled trials in our database, 195 compared volunteers’ response to a vaccine with their response to a placebo. Of those, 159 gave volunteers only a salt water solution or another inert substance. Another 36 gave them just the adjuvant without any viral or bacterial material, as a way to see whether there were side effects from the antigen itself or the injection. Every routine childhood vaccine antigen appears in at least one such study.

The 1954 Salk polio trial, one of the largest clinical trials in medical history, enrolled more than 600,000 children and tested the vaccine by comparing it with a salt water control. Similar trials, which used a substance that has no biological effect as a control, were used to test Haemophilus influenzae type b, pneumococcal, rotavirus, influenza and HPV vaccines.

Once an effective vaccine exists, ethics boards require new versions be compared against that licensed standard because withholding proven protection from children would be unethical.

How unknown is the safety of widely used vaccines?

Kennedy has insisted on multiple occasions that “nobody has any idea” about vaccine safety profiles. Of the 378 trials in our database, the vast majority published detailed safety outcomes.

Beyond trials, the U.S. operates the Vaccine Adverse Event Reporting System, the Vaccine Safety Datalink and the PRISM network to monitor hundreds of millions of doses for rare problems. The Vaccine Adverse Event Reporting System works like an open mailbox where anyone – patients, parents, clinicians – can report a post-shot problem; the Vaccine Safety Datalink analyzes anonymized electronic health records from large health care systems to spot patterns; and PRISM scans billions of insurance claims in near-real time to confirm or rule out rare safety signals.

These systems led health officials to pull the first rotavirus vaccine in 1999 after it was linked to bowel obstruction, and to restrict the Johnson & Johnson COVID-19 vaccine in 2021 after rare clotting events. Few drug classes undergo such continuous surveillance and are subject to such swift corrective action when genuine risks emerge.

The conflicts of interest claim

On June 9, Kennedy took the unprecedented step of dissolving vetted members of the Advisory Committee on Immunization Practices, the expert body that advises the CDC on national vaccine policy. He has claimed repeatedly that the vast majority of serving members of the committee – 97% – had extensive conflicts of interest because of their entanglements with the pharmaceutical industry. Kennedy bases that number on a 2009 federal audit of conflict-of-interest paperwork, but that report looked at 17 CDC advisory committees, not specifically this vaccine committee. And it found no pervasive wrongdoing – 97% of disclosure forms only contained routine paperwork mistakes, such as information in the wrong box or a missing initial, and not hidden financial ties.

Reuters examined data from Open Payments, a government website that discloses health care providers’ relationships with industry, for all 17 voting members of the committee who were dismissed. Six received no more than US$80 from drugmakers over seven years, and four had no payments at all.

The remaining seven members accepted between $4,000 and $55,000 over seven years, mostly for modest consulting or travel. In other words, just 41% of the committee received anything more than pocket change from drugmakers. Committee members must divest vaccine company stock and recuse themselves from votes involving conflicts.

A term without a meaning

Kennedy has warned that vaccines cause “immune deregulation,” a term that has no basis in immunology. Vaccines train the immune system, and the diseases they prevent are the real threats to immune function.

Measles can wipe immune memory, leaving children vulnerable to other infections for years. COVID-19 can trigger multisystem inflammatory syndrome in children. Chronic hepatitis B can cause immune-mediated organ damage. Preventing these conditions protects people from immune system damage.

Today’s vaccine panel doesn’t just prevent infections; it deters doctor visits and thereby reduces unnecessary prescriptions for “just-in-case” antibiotics. It’s one of the rare places in medicine where physicians like me now do more good with less biological burden than we did 40 years ago.

The evidence is clear and publicly available: Vaccines have dramatically reduced childhood illness, disability and death on a historic scale.The Conversation

Jake Scott, Clinical Associate Professor of Infectious Diseases, Stanford University

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Read More

The post I’m a physician who has looked at hundreds of studies of vaccine safety, and here’s some of what RFK Jr. gets wrong appeared first on theconversation.com



Note: The following A.I. based commentary is not part of the original article, reproduced above, but is offered in the hopes that it will promote greater media literacy and critical thinking, by making any potential bias more visible to the reader –Staff Editor.

Political Bias Rating: Center-Left

This content presents a science-based and fact-checked critique of Robert F. Kennedy Jr.’s statements on vaccines, emphasizing the importance of established public health measures and vaccine safety. It supports mainstream medical consensus and public health institutions like the CDC, while challenging anti-vaccine rhetoric associated with certain political or ideological positions. The tone is objective but leans toward defending regulatory agencies and vaccine advocacy, which aligns more closely with Center-Left perspectives favoring public health expertise and government intervention in health policy.

Continue Reading

The Conversation

Cyberattacks shake voters’ trust in elections, regardless of party

Published

on

theconversation.com – Ryan Shandler, Professor of Cybersecurity and International Relations, Georgia Institute of Technology – 2025-06-27 07:29:00


American democracy faces a crisis of trust, with nearly half of Americans doubting election fairness. This mistrust stems not only from polarization and misinformation but also from unease about the digital infrastructure behind voting. While over 95% of ballots are now counted electronically, this complexity fuels skepticism, especially amid foreign disinformation campaigns that amplify doubts about election security. A study during the 2024 election showed that exposure to cyberattack reports, even unrelated to elections, significantly undermines voter confidence, particularly among those using digital voting machines. To protect democracy, it’s vital to pair secure technology with public education and treat trust as a national asset.

An election worker installs a touchscreen voting machine.
Ethan Miller/Getty Images

Ryan Shandler, Georgia Institute of Technology; Anthony J. DeMattee, Emory University, and Bruce Schneier, Harvard Kennedy School

American democracy runs on trust, and that trust is cracking.

Nearly half of Americans, both Democrats and Republicans, question whether elections are conducted fairly. Some voters accept election results only when their side wins. The problem isn’t just political polarization – it’s a creeping erosion of trust in the machinery of democracy itself.

Commentators blame ideological tribalism, misinformation campaigns and partisan echo chambers for this crisis of trust. But these explanations miss a critical piece of the puzzle: a growing unease with the digital infrastructure that now underpins nearly every aspect of how Americans vote.

The digital transformation of American elections has been swift and sweeping. Just two decades ago, most people voted using mechanical levers or punch cards. Today, over 95% of ballots are counted electronically. Digital systems have replaced poll books, taken over voter identity verification processes and are integrated into registration, counting, auditing and voting systems.

This technological leap has made voting more accessible and efficient, and sometimes more secure. But these new systems are also more complex. And that complexity plays into the hands of those looking to undermine democracy.

In recent years, authoritarian regimes have refined a chillingly effective strategy to chip away at Americans’ faith in democracy by relentlessly sowing doubt about the tools U.S. states use to conduct elections. It’s a sustained campaign to fracture civic faith and make Americans believe that democracy is rigged, especially when their side loses.

This is not cyberwar in the traditional sense. There’s no evidence that anyone has managed to break into voting machines and alter votes. But cyberattacks on election systems don’t need to succeed to have an effect. Even a single failed intrusion, magnified by sensational headlines and political echo chambers, is enough to shake public trust. By feeding into existing anxiety about the complexity and opacity of digital systems, adversaries create fertile ground for disinformation and conspiracy theories.

Just before the 2024 presidential election, Director of the Cybersecurity and Infrastructure Security Agency Jen Easterly explains how foreign influence campaigns erode trust in U.S. elections.

Testing cyber fears

To test this dynamic, we launched a study to uncover precisely how cyberattacks corroded trust in the vote during the 2024 U.S. presidential race. We surveyed more than 3,000 voters before and after election day, testing them using a series of fictional but highly realistic breaking news reports depicting cyberattacks against critical infrastructure. We randomly assigned participants to watch different types of news reports: some depicting cyberattacks on election systems, others on unrelated infrastructure such as the power grid, and a third, neutral control group.

The results, which are under peer review, were both striking and sobering. Mere exposure to reports of cyberattacks undermined trust in the electoral process – regardless of partisanship. Voters who supported the losing candidate experienced the greatest drop in trust, with two-thirds of Democratic voters showing heightened skepticism toward the election results.

But winners too showed diminished confidence. Even though most Republican voters, buoyed by their victory, accepted the overall security of the election, the majority of those who viewed news reports about cyberattacks remained suspicious.

The attacks didn’t even have to be related to the election. Even cyberattacks against critical infrastructure such as utilities had spillover effects. Voters seemed to extrapolate: “If the power grid can be hacked, why should I believe that voting machines are secure?”

Strikingly, voters who used digital machines to cast their ballots were the most rattled. For this group of people, belief in the accuracy of the vote count fell by nearly twice as much as that of voters who cast their ballots by mail and who didn’t use any technology. Their firsthand experience with the sorts of systems being portrayed as vulnerable personalized the threat.

It’s not hard to see why. When you’ve just used a touchscreen to vote, and then you see a news report about a digital system being breached, the leap in logic isn’t far.

Our data suggests that in a digital society, perceptions of trust – and distrust – are fluid, contagious and easily activated. The cyber domain isn’t just about networks and code. It’s also about emotions: fear, vulnerability and uncertainty.

Firewall of trust

Does this mean we should scrap electronic voting machines? Not necessarily.

Every election system, digital or analog, has flaws. And in many respects, today’s high-tech systems have solved the problems of the past with voter-verifiable paper ballots. Modern voting machines reduce human error, increase accessibility and speed up the vote count. No one misses the hanging chads of 2000.

But technology, no matter how advanced, cannot instill legitimacy on its own. It must be paired with something harder to code: public trust. In an environment where foreign adversaries amplify every flaw, cyberattacks can trigger spirals of suspicion. It is no longer enough for elections to be secure − voters must also perceive them to be secure.

That’s why public education surrounding elections is now as vital to election security as firewalls and encrypted networks. It’s vital that voters understand how elections are run, how they’re protected and how failures are caught and corrected. Election officials, civil society groups and researchers can teach how audits work, host open-source verification demonstrations and ensure that high-tech electoral processes are comprehensible to voters.

We believe this is an essential investment in democratic resilience. But it needs to be proactive, not reactive. By the time the doubt takes hold, it’s already too late.

Just as crucially, we are convinced that it’s time to rethink the very nature of cyber threats. People often imagine them in military terms. But that framework misses the true power of these threats. The danger of cyberattacks is not only that they can destroy infrastructure or steal classified secrets, but that they chip away at societal cohesion, sow anxiety and fray citizens’ confidence in democratic institutions. These attacks erode the very idea of truth itself by making people doubt that anything can be trusted.

If trust is the target, then we believe that elected officials should start to treat trust as a national asset: something to be built, renewed and defended. Because in the end, elections aren’t just about votes being counted – they’re about people believing that those votes count.

And in that belief lies the true firewall of democracy.The Conversation

Ryan Shandler, Professor of Cybersecurity and International Relations, Georgia Institute of Technology; Anthony J. DeMattee, Data Scientist and Adjunct Instructor, Emory University, and Bruce Schneier, Adjunct Lecturer in Public Policy, Harvard Kennedy School

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Read More

The post Cyberattacks shake voters’ trust in elections, regardless of party appeared first on theconversation.com



Note: The following A.I. based commentary is not part of the original article, reproduced above, but is offered in the hopes that it will promote greater media literacy and critical thinking, by making any potential bias more visible to the reader –Staff Editor.

Political Bias Rating: Centrist

This article presents a balanced and fact-focused analysis of trust issues surrounding American elections, emphasizing concerns shared across the political spectrum. It highlights the complexity of digital voting infrastructure and the external threats posed by misinformation and foreign influence without promoting partisan viewpoints. The tone is neutral, grounded in data and research, avoiding ideological framing or advocacy. The piece calls for bipartisan solutions like public education and institutional trust-building, reflecting a centrist perspective that prioritizes democratic resilience over partisan blame.

Continue Reading

Trending